Science-based COVID-19 vaccine development.
作者信息
Gao George F
机构信息
Institute of Microbiology, Chinese Academy of Sciences, China.
出版信息
Natl Sci Rev. 2021 Nov 3;8(10):nwab193. doi: 10.1093/nsr/nwab193. eCollection 2021 Oct.
Abstract
摘要
相似文献
1
Science-based COVID-19 vaccine development.基于科学的新冠疫苗研发。
Natl Sci Rev. 2021 Nov 3;8(10):nwab193. doi: 10.1093/nsr/nwab193. eCollection 2021 Oct.
2
Science and religion for COVID-19 vaccine promotion.科学和宗教助力新冠疫苗推广。
J Public Health (Oxf). 2021 Sep 22;43(3):e513-e514. doi: 10.1093/pubmed/fdab128.
3
Science, religion and state: a multidimensional perspective.科学、宗教与国家：多维度视角
J Public Health (Oxf). 2021 Sep 22;43(3):e547-e548. doi: 10.1093/pubmed/fdab152.
4
Mistrust and Beliefs in Conspiracy Theories Differently Mediate the Effects of Psychological Factors on Propensity for COVID-19 Vaccine.对阴谋论的不信任和信念对心理因素影响新冠疫苗接种倾向的作用存在不同的中介效应。
Front Psychol. 2021 Jul 7;12:683684. doi: 10.3389/fpsyg.2021.683684. eCollection 2021.
5
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
6
COVID-19 Vaccine Hesitancy in Canada: Content Analysis of Tweets Using the Theoretical Domains Framework.加拿大对 COVID-19 疫苗的犹豫：使用理论领域框架对推文的内容分析。
J Med Internet Res. 2021 Apr 13;23(4):e26874. doi: 10.2196/26874.
7
Transforming vaccine development.变革疫苗研发。
Semin Immunol. 2020 Aug;50:101413. doi: 10.1016/j.smim.2020.101413. Epub 2020 Oct 28.
8
Super-rapid race for saving lives by developing COVID-19 vaccines.超级快速研发 COVID-19 疫苗以拯救生命。
J Integr Bioinform. 2021 Mar 25;18(1):27-43. doi: 10.1515/jib-2021-0002.
9
Digging the rabbit hole, COVID-19 edition: anti-vaccine themes and the discourse around COVID-19.挖掘兔子洞，COVID-19 版：反疫苗主题和围绕 COVID-19 的论述。
Microbes Infect. 2020 Nov-Dec;22(10):608-610. doi: 10.1016/j.micinf.2020.11.001. Epub 2020 Nov 7.
10
COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.COVID-19 疫苗在孕妇和幼儿母亲中的接受度：16 个国家调查结果。
Eur J Epidemiol. 2021 Feb;36(2):197-211. doi: 10.1007/s10654-021-00728-6. Epub 2021 Mar 1.
引用本文的文献
1
A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants.一种含有 S-RBD 和 HA 的嵌合 mRNA 疫苗，可提供针对流感和 COVID-19 变体的广泛保护。
PLoS Pathog. 2024 Sep 20;20(9):e1012508. doi: 10.1371/journal.ppat.1012508. eCollection 2024 Sep.
2
Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex.广谱 Delta-BA.2 串联融合异源二聚体 mRNA 疫苗，采用脂质多聚物递送。
PLoS Pathog. 2024 Apr 1;20(4):e1012116. doi: 10.1371/journal.ppat.1012116. eCollection 2024 Apr.
3
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.定义一种新的非 RBM 抗体为 RBD-8，它与免疫逃逸抗体协同作用，以中和奥密克戎 SARS-CoV-2。
Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2314193120. doi: 10.1073/pnas.2314193120. Epub 2023 Dec 18.
4
Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China.中国新冠疫情防控政策调整后即时突破性感染的抗体反应评估
Lancet Reg Health West Pac. 2023 Nov 15;40:100945. doi: 10.1016/j.lanwpc.2023.100945. eCollection 2023 Nov.
5
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals.异源加强免疫 PastoCovac Plus 对 ChAdOx1-S 或 BBIBP-CorV 初免个体的 COVID-19 免疫原性和安全性。
PLoS Pathog. 2023 Nov 1;19(11):e1011744. doi: 10.1371/journal.ppat.1011744. eCollection 2023 Nov.
6
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD.设计一种具有 HA 茎和 S-RBD 的流感-新冠嵌合保护疫苗的合理性。
Emerg Microbes Infect. 2023 Dec;12(2):2231573. doi: 10.1080/22221751.2023.2231573.
7
Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats.重组蛋白亚单位新冠病毒疫苗（ZF2001）对大鼠的发育和生殖毒性
NPJ Vaccines. 2023 May 24;8(1):74. doi: 10.1038/s41541-023-00673-3.
8
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.针对当前流行的奥密克戎亚变体，对异源嵌合RBD二聚体mRNA疫苗作为灭活疫苗后的加强针进行快速评估。
Biosaf Health. 2023 Apr;5(2):89-100. doi: 10.1016/j.bsheal.2023.02.002. Epub 2023 Mar 2.
9
Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study.中国中部地区 2019 年冠状病毒病（COVID-19）灭活疫苗对体液和细胞免疫应答的特征：一项前瞻性、多中心、纵向研究。
Front Immunol. 2023 Mar 3;14:1107866. doi: 10.3389/fimmu.2023.1107866. eCollection 2023.
10
Safety and immunogenicity of inactivated COVID-19 vaccine CoronaVac and the RBD-dimer-based COVID-19 vaccine ZF2001 in chronic hepatitis B patients.灭活新冠疫苗科兴中维（CoronaVac）和基于RBD二聚体的新冠疫苗ZF2001在慢性乙型肝炎患者中的安全性和免疫原性。
Front Med (Lausanne). 2023 Feb 8;10:1078666. doi: 10.3389/fmed.2023.1078666. eCollection 2023.
本文引用的文献
1
Guangdong's Study of the Effectiveness of China's Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant.广东关于中国新冠病毒灭活疫苗对SARS-CoV-2 B.1.617.2（德尔塔）变异株有效性的研究
China CDC Wkly. 2021 Aug 20;3(34):728-730. doi: 10.46234/ccdcw2021.179.
2
A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020.在中国武汉2019 - 2020年肺炎病例群中发现的一种新型冠状病毒基因组
China CDC Wkly. 2020 Jan 24;2(4):61-62.
3
Viral targets for vaccines against COVID-19.针对 COVID-19 的疫苗的病毒靶点。
Nat Rev Immunol. 2021 Feb;21(2):73-82. doi: 10.1038/s41577-020-00480-0. Epub 2020 Dec 18.
4
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
5
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
Zotero 插件